Edap Tms' (EDAP) Buy Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Edap Tms (NASDAQ:EDAP - Free Report) in a research report report published on Friday,Benzinga reports. HC Wainwright currently has a $19.00 price target on the medical equipment provider's stock. HC Wainwright also issued estimates for Edap Tms' FY2029 earnings at $0.40 EPS.

Separately, StockNews.com began coverage on Edap Tms in a research report on Friday. They set a "hold" rating for the company.

Edap Tms Stock Performance

NASDAQ EDAP traded up $0.09 on Friday, reaching $2.05. The stock had a trading volume of 77,062 shares, compared to its average volume of 87,365. Edap Tms has a 1-year low of $1.90 and a 1-year high of $8.50. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. The company has a market cap of $76.06 million, a P/E ratio of -3.22 and a beta of 0.37. The firm has a fifty day moving average of $2.42 and a two-hundred day moving average of $2.49.

Edap Tms (NASDAQ:EDAP - Get Free Report) last released its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.06. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The business had revenue of $22.69 million for the quarter, compared to analyst estimates of $20.83 million. On average, equities research analysts anticipate that Edap Tms will post -0.6 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Illumine Investment Management LLC acquired a new stake in shares of Edap Tms in the 4th quarter valued at $50,000. BNP Paribas Financial Markets boosted its stake in Edap Tms by 23.7% in the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider's stock valued at $59,000 after buying an additional 4,400 shares in the last quarter. Jane Street Group LLC grew its position in Edap Tms by 174.7% in the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock valued at $69,000 after acquiring an additional 73,361 shares during the last quarter. Millennium Management LLC raised its stake in Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock worth $108,000 after acquiring an additional 33,558 shares in the last quarter. Finally, Orion Capital Management LLC lifted its holdings in shares of Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider's stock worth $178,000 after acquiring an additional 6,600 shares during the last quarter. 62.74% of the stock is owned by institutional investors.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.